| 000 | 01730 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516233807.0 | ||
| 264 | 0 | _c20150921 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1864-6433 | ||
| 024 | 7 |
_a10.1007/s12149-014-0908-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuo, Tsai-Yueh | |
| 245 | 0 | 0 |
_a188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells. _h[electronic resource] |
| 260 |
_bAnnals of nuclear medicine _cJan 2015 |
||
| 300 |
_a52-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazines _xtherapeutic use |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 |
_aNicotinic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aRadioimmunotherapy |
| 650 | 0 | 4 |
_aRadioisotopes _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aRhenium _xtherapeutic use |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aCheng, Po-Ching | |
| 700 | 1 | _aChiang, Ping-Fang | |
| 700 | 1 | _aChuang, Ting-Wu | |
| 700 | 1 | _aYeh, Chung-Hsin | |
| 700 | 1 | _aLin, Wuu-Jyh | |
| 773 | 0 |
_tAnnals of nuclear medicine _gvol. 29 _gno. 1 _gp. 52-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12149-014-0908-8 _zAvailable from publisher's website |
| 999 |
_c24206178 _d24206178 |
||